Investigating how a specific genetic mutation affects nerve cell development

The role of the dz217 mutation in somatosensory dendrite morphogenesis

['FUNDING_R01'] · ALBERT EINSTEIN COLLEGE OF MEDICINE · NIH-11232157

This study is looking at how certain genes affect the growth of tiny branches on nerve cells, which are important for how our brain works, and it uses a small worm called C. elegans to see how a specific mutation changes these branches; the goal is to learn more about how nerve cells connect, which could help us understand conditions like autism better.

Quick facts

Phase['FUNDING_R01']
Study typeNih_funding
SexAll
SponsorALBERT EINSTEIN COLLEGE OF MEDICINE (nih funded)
Locations1 site (BRONX, UNITED STATES)
Trial IDNIH-11232157 on ClinicalTrials.gov

What this research studies

This research focuses on understanding the genetic and molecular mechanisms that influence the development of dendrites, which are essential for proper neural circuit function. Using the model organism C. elegans, the study examines how the dz217 mutation impacts the branching of dendrites in specific neurons. By identifying genetic factors that regulate dendrite morphology, the research aims to uncover fundamental insights into how nerve cells communicate and function. This could lead to a better understanding of conditions like autism spectrum disorder, where neural connectivity may be affected.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals with autism spectrum disorder or those interested in the genetic factors influencing neural development.

Not a fit: Patients without autism spectrum disorder or those not affected by genetic mutations related to dendrite development may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could provide insights into the biological underpinnings of autism spectrum disorder, potentially leading to new therapeutic strategies.

How similar studies have performed: Previous research has shown success in using genetic models like C. elegans to study neural development, indicating that this approach is promising.

Where this research is happening

BRONX, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.

View on NIH RePORTER →

Conditions: autism spectral disorder, autism spectrum disorder, Autistic Disorder, autistic spectrum disorder

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.